Kodiak Sciences (KOD) Net Equity Issued and Repurchased (2018 - 2019)
Kodiak Sciences' (KOD) quarterly Net Equity Issued and Repurchased came in at $297.6 million in Q4 2019, up 255.53% YoY from $83.7 million in Q4 2018, and up 99100.0% on a QoQ basis from $300000.0 in Q3 2019.
Analysis
Kodiak Sciences (KOD) Net Equity Issued and Repurchased (2018 - 2019) Analysis & Trends
Kodiak Sciences (KOD) has 2 years of Net Equity Issued and Repurchased data on file, last reported at $297.6 million in Q4 2019.
- Quarterly Net Equity Issued and Repurchased rose 255.53% year-over-year to $297.6 million in Q4 2019, while the trailing twelve-month figure through Dec 2019 was $298.0 million (up 255.82% YoY) and the FY2020 annual result came in at $612.0 million, up 105.64% from the prior year.
- Net Equity Issued and Repurchased rose to $297.6 million in Q4 2019, from $300000.0 in the prior quarter.
- In the past five years, Net Equity Issued and Repurchased ranged from a high of $297.6 million in Q4 2019 to a low of $31000.0 in Q2 2019.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 49.20 Mn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 141.90 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | - |
| 10 | Kodiak Sciences | 2.21 Bn | 2.21 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2019 | 297.60 Mn |
| Sep 30, 2019 | 300,000.00 |
| Jun 30, 2019 | 31,000.00 |
| Mar 31, 2019 | 83,000.00 |
| Dec 31, 2018 | 83.71 Mn |
| Sep 30, 2018 | 49,000.00 |